⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo ® in France, Denmark, Iceland, Sweden, Finland and Norway
businesswire.com
OGN
Orogen Royalties Notes Initial Resource Estimate on Kodiak Copper's MPD Copper-Gold Project
accessnewswire.com
KDK
OGN
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
businesswire.com
OGN
Henlius and Organon Announce US FDA Approval of POHERDY ® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
businesswire.com
OGN
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
businesswire.com
OGN
Organon Reports Results for the Third Quarter Ended September 30, 2025
businesswire.com
OGN
New Data Show Early and Consistent Response to VTAMA ® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
businesswire.com
OGN
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
prnewswire.com
OGN
Organon Announces Agreement to Divest its JADA ® System for Up to $465 Million to Laborie
businesswire.com
OGN
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
businesswire.com
OGN